NRX Pharmaceuticals Q1 2026 Earnings Wider Loss Despite No Revenue Stock Advances QMCO Q1 2026 Earnings EPS Beat Estimates but Stock Declines as Revenue Remains Unreported Tenable Holdings Q1 2026 Earnings EPS Surprises Positively Revenue Detail Not Disclosed AMPG Q1 2026 Earnings EPS Misses Estimates as Challenges Persist CANF Q4 2023 Earnings EPS Surprise of 96 as Biotech Reports NarrowerThanExpected Loss BJDX Q4 2023 Earnings EPS Falls Far Below Estimates Revenue Remains Absent IBP Q1 2026 Earnings Earnings Miss Prediction Despite Positive Stock Reaction Enveric Biosciences Inc ENVB Q4 2024 Earnings Massive EPS Miss Highlights Ongoing Cash Burn and No Revenue SolGel Technologies SLGL Q4 2025 Earnings DevelopmentStage Miss Deepens as Losses Widen Stock Surges LBRDK Q3 2025 Earnings EPS Surges Past Estimates Stock Reacts Modestly Azitra Inc AZTR Q1 2026 Earnings WiderThanExpected Loss Amid PreRevenue Stage DVS Q4 2025 Earnings Silver Developer Reports WiderThanExpected Loss Amid PreRevenue Phase